Table 1.
Baseline Characteristics of Participants
| Characteristics | Control (N = 45) | Educational Intervention (N = 45) | P Value |
|---|---|---|---|
| Age in years (mean ± SD) | 46.8 ± 10.3 | 46.0 ± 10.4 | 0.72 |
| Sex, n (%) | 0.67 | ||
| Female | 20 (44.4) | 22 (48.9) | |
| Male | 25 (55.6) | 23 (51.0) | |
| Specialty, n (%) | 0.82 | ||
| General neurologists who care for MS patients | 29 (64.4) | 30 (66.7) | |
| MS specialists | 16 (35.6) | 15 (33.3) | |
| Practice setting, n (%) | 0.37 | ||
| Public | 17 (37.8) | 13 (28.9) | |
| Private | 28 (62.2) | 32 (71.1) | |
| % time in clinical practice, n (%) | |||
| >75% | 19 (42.2) | 20 (44.4) | 0.83 |
| Years in practice (mean ± SD) | 21.1 ± 10.5 | 19.5 ± 11 | 0.48 |
| MS patients seen per week (mean ± SD) | 21.8 ± 4.5 | 23.0 ± 8.3 | 0.37 |
| Author of a peer-reviewed publication in the last 1 year, n (%) | 20 (44.4) | 23 (51.1) | 0.53 |
| Restriction to prescribe MS drugs, n (%) | 0.83 | ||
| No restrictions | 28 (62.2) | 29 (64.4) | |
| Treatment escalation, mean drugs (±SD) | 2.91 (1.24) | 3.09 (2.05) | 0.62 |
MS, multiple sclerosis